Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2009 (2009), Article ID 187894, 5 pages
http://dx.doi.org/10.1155/2009/187894
Hypothesis

Interleukin-10: A Key Cytokine in Depression?

Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal

Received 8 May 2009; Accepted 23 June 2009

Academic Editor: Hari Manev

Copyright © 2009 Susana Roque et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Wrona, “Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems,” Journal of Neuroimmunology, vol. 172, pp. 38–58, 2006. View at Google Scholar
  2. M. R. Irwin and A. H. Miller, “Depressive disorders and immunity: 20 years of progress and discovery,” Brain, Behavior, and Immunity, vol. 21, no. 4, pp. 374–383, 2007. View at Publisher · View at Google Scholar
  3. S. Moussavi, S. Chatterji, E. Verdes, A. Tandon, V. Patel, and B. Ustun, “Depression, chronic diseases, and decrements in health: results from the World Health Surveys,” Lancet, vol. 370, no. 9590, pp. 851–858, 2007. View at Publisher · View at Google Scholar
  4. R. S. Smith, “The macrophage theory of depression,” Medical Hypotheses, vol. 35, pp. 298–306, 1991. View at Google Scholar
  5. C. L. Raison, L. Capuron, and A. H. Miller, “Cytokines sing the blues: inflammation and the pathogenesis of depression,” Trends in Immunology, vol. 27, no. 1, pp. 24–31, 2006. View at Publisher · View at Google Scholar
  6. M. Maes, “Evidence for an immune response in major depression: a review and hypothesis,” Progress in Neuropsychopharmacol and Biological Psychiatry, vol. 19, pp. 11–38, 1995. View at Google Scholar
  7. H. Anisman, A. V. Ravindran, J. Griffiths, and Z. Merali, “Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features,” Molecular Psychiatry, vol. 4, no. 2, pp. 182–188, 1999. View at Google Scholar
  8. L. Capuron and A. H. Miller, “Cytokines and psychopathology: lessons from interferon-α,” Biological Psychiatry, vol. 56, no. 11, pp. 819–824, 2004. View at Publisher · View at Google Scholar
  9. S. Bonaccorso, H. Meltzer, and M. Maes, “Psychological and behavioural effects of interferons,” Current Opinion in Psychiatry, vol. 13, no. 6, pp. 673–677, 2000. View at Publisher · View at Google Scholar
  10. M. Maes, S. Bonaccorso, V. Marino et al., “Treatment with interferon-alpha (IFNa) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFNa-induced depressive and anxiety symptoms and immune activation,” Molecular Psychiatry, vol. 6, no. 4, pp. 475–480, 2001. View at Publisher · View at Google Scholar
  11. D. L. Musselman, D. H. Lawson, J. F. Gumnick et al., “Paroxetine for the prevention of depression induced by high-dose interferon alfa,” New England Journal of Medicine, vol. 344, no. 13, pp. 961–966, 2001. View at Publisher · View at Google Scholar
  12. R. Dantzer, J. C. O'Connor, G. G. Freund, R. W. Johnson, and K. W. Kelley, “From inflammation to sickness and depression: when the immune system subjugates the brain,” Nature Reviews Neuroscience, vol. 9, no. 1, pp. 46–56, 2008. View at Publisher · View at Google Scholar
  13. I. Goshen, T. Kreisel, O. Ben-Menachem-Zidon et al., “Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression,” Molecular Psychiatry, vol. 13, no. 7, pp. 717–728, 2008. View at Publisher · View at Google Scholar
  14. B. B. Simen, C. H. Duman, A. A. Simen, and R. S. Duman, “TNFα signaling in depression and anxiety: behavioral consequences of individual receptor targeting,” Biological Psychiatry, vol. 59, no. 9, pp. 775–785, 2006. View at Publisher · View at Google Scholar
  15. A. R. Mesquita, M. Correia-Neves, S. Roque et al., “IL-10 modulates depressive-like behavior,” Journal of Psychiatric Research, vol. 43, no. 2, pp. 89–97, 2008. View at Publisher · View at Google Scholar
  16. R. H. Belmaker and G. Agam, “Major depressive disorder,” New England Journal of Medicine, vol. 358, no. 1, pp. 55–68, 2008. View at Publisher · View at Google Scholar
  17. M. R. Opp, E. M. Smith, and T. K. Hughes Jr., “Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep,” Journal of Neuroimmunology, vol. 60, no. 1-2, pp. 165–168, 1995. View at Publisher · View at Google Scholar
  18. T. Kushikata, J. Fang, and J. M. Krueger, “Interleukin-10 inhibits spontaneous sleep in rabbits,” Journal of Interferon and Cytokine Research, vol. 19, no. 9, pp. 1025–1030, 1999. View at Publisher · View at Google Scholar
  19. L. A. Toth and M. R. Opp, “Cytokine- and microbially induced sleep responses of interleukin-10 deficient mice,” American Journal of Physiology, vol. 280, no. 6, pp. R1806–R1814, 2001. View at Google Scholar
  20. M. J. Bair, R. L. Robinson, W. Katon, and K. Kroenke, “Depression and pain comorbidity: a literature review,” Archives of Internal Medicine, vol. 163, no. 20, pp. 2433–2445, 2003. View at Publisher · View at Google Scholar
  21. H. Tu, T. Juelich, E. M. Smith, S.K. Tyring, P. L. Rady, and T. K. Hughes Jr., “Evidence for endogenous interleukin-10 during nociception,” Journal of Neuroimmunology, vol. 139, no. 1-2, pp. 145–149, 2003. View at Publisher · View at Google Scholar
  22. M. Kubera, M. Maes, V. Holan, A. Basta-Kaim, A. Roman, and J. Shani, “Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression,” Journal of Affective Disorders, vol. 63, no. 1–3, pp. 171–178, 2001. View at Publisher · View at Google Scholar
  23. M. Kubera, A.-H. Lin, G. Kenis, E. Bosmans, D. van Bockstaele, and M. Maes, “Anti-inflammatory effects of antidepressants through suppression of the interferon-γ/interleukin-10 production ratio,” Journal of Clinical Psychopharmacology, vol. 21, no. 2, pp. 199–206, 2001. View at Publisher · View at Google Scholar
  24. G. Kenis and M. Maes, “Effects of antidepressants on the production of cytokines,” International Journal of Neuropsychopharmacology, vol. 5, no. 4, pp. 401–412, 2002. View at Publisher · View at Google Scholar
  25. M. Maes, C. Song, A.-H. Lin et al., “Negative immunoregulatory effects of antidepressants inhibition of interferon-? and stimulation of interleukin-10 secretion,” Neuropsychopharmacology, vol. 20, no. 4, pp. 370–379, 1999. View at Publisher · View at Google Scholar
  26. K. W. Moore, R. de Waal Malefyt, R. L. Coffman, and A. O'Garra, “Interleukin-10 and the interleukin-10 receptor,” Annual Review of Immunology, vol. 19, pp. 683–765, 2001. View at Publisher · View at Google Scholar
  27. D. Harvey, R. Smith, K. English, B. Mahon, and S. Commins, “Interleukin-10 (IL-10) but not Lipopolysaccharide (LPS) produces increased motor activity and abnormal exploratory patterns while impairing spatial learning in Balb/c mice,” Physiology and Behavior, vol. 87, no. 5, pp. 842–847, 2006. View at Publisher · View at Google Scholar
  28. A. J. Kastin, V. Akerstrom, and W. Pan, “Interleukin-10 as a CNS therapeutic: the obstacle of the blood-brain/blood-spinal cord barrier,” Molecular Brain Research, vol. 114, no. 2, pp. 168–171, 2003. View at Publisher · View at Google Scholar
  29. L. Vitkovic, S. Maeda, and E. Sternberg, “Anti-inflammatory cytokines: expression and action in the brain,” NeuroImmunoModulation, vol. 9, no. 6, pp. 295–312, 2001. View at Publisher · View at Google Scholar
  30. A. Ledeboer, J. J. P. Brevé, A. Wierinckx et al., “Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells,” European Journal of Neuroscience, vol. 16, no. 7, pp. 1175–1185, 2002. View at Publisher · View at Google Scholar
  31. N. Quan and W. A. Banks, “Brain-immune communication pathways,” Brain, Behavior, and Immunity, vol. 21, no. 6, pp. 727–735, 2007. View at Publisher · View at Google Scholar
  32. F. Marques, J. C. Sousa, G. Coppola et al., “Kinetic profile of the transcriptome changes induced in the choroid plexus by peripheral inflammation,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 5, pp. 921–932, 2009. View at Publisher · View at Google Scholar
  33. E. Molina-Holgado, J. M. Vela, A. Arévalo-Martín, and C. Guaza, “LPS/IFN-γ cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10,” European Journal of Neuroscience, vol. 13, no. 3, pp. 493–502, 2001. View at Publisher · View at Google Scholar
  34. H. Ward, S. Vigues, S. Poole, and A. F. Bristow, “The rat interleukin 10 receptor: cloning and sequencing of cDNA coding for the alpha-chain protein sequence, and demonstration by western blotting of expression in the rat brain,” Cytokine, vol. 15, no. 5, pp. 237–240, 2001. View at Publisher · View at Google Scholar
  35. K. Pahan, M. Khan, and I. Singh, “Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3- kinase,” Journal of Neurochemistry, vol. 75, no. 2, pp. 576–582, 2000. View at Publisher · View at Google Scholar
  36. K. Strle, J.-H. Zhou, S. R. Broussard et al., “IL-10 promotes survival of microglia without activating Akt,” Journal of Neuroimmunology, vol. 122, no. 1-2, pp. 9–19, 2002. View at Publisher · View at Google Scholar
  37. A. Bachis, A. M. Colangelo, S. Vicini et al., “Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity,” Journal of Neuroscience, vol. 21, no. 9, pp. 3104–3112, 2001. View at Google Scholar
  38. P. J. Lucassen, G. K. Vollmann-Honsdorf, M. Gleisberg, B. Czéh, E. R. De Kloet, and E. Fuchs, “Chronic psychosocial stress differentially affects apoptosis in hippocampal subregions and cortex of the adult tree shrew,” European Journal of Neuroscience, vol. 14, no. 1, pp. 161–166, 2001. View at Publisher · View at Google Scholar
  39. E. M. Smith, P. Cadet, G. B. Stefano, M. R. Opp, and T. K. Hughes Jr., “IL-10 as a mediator in the HPA axis and brain,” Journal of Neuroimmunology, vol. 100, no. 1-2, pp. 140–148, 1999. View at Publisher · View at Google Scholar
  40. C. L. Raison and A. H. Miller, “When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders,” American Journal of Psychiatry, vol. 160, no. 9, pp. 1554–1565, 2003. View at Publisher · View at Google Scholar
  41. N. Koldzic-Zivanovic, H. Tu, T. L. Juelich et al., “Regulation of adrenal glucocorticoid synthesis by interleukin-10: a preponderance of IL-10 receptor in the adrenal zona fasciculata,” Brain, Behavior, and Immunity, vol. 20, no. 5, pp. 460–468, 2006. View at Publisher · View at Google Scholar
  42. H. Tu, P. L. Rady, T. Juelich et al., “Interleukin-10 regulated gene expression in cells of hypothalamic- pituitary-adrenal axis origin,” Cellular and Molecular Neurobiology, vol. 27, no. 2, pp. 161–170, 2007. View at Publisher · View at Google Scholar
  43. T. K. Hughes, P. Cadet, P. L. Rady, S. K. Tyring, R. Chin, and E. M. Smith, “Evidence for the production and action of interleukin-10 in pituitary cells,” Cellular and Molecular Neurobiology, vol. 14, no. 1, pp. 59–69, 1994. View at Publisher · View at Google Scholar
  44. P. L. Rady, E. M. Smith, P. Cadet, M. R. Opp, S. K. Tyring, and T. K. Hughes Jr., “Presence of interleukin-10 transcripts in human pituitary and hypothalamus,” Cellular and Molecular Neurobiology, vol. 15, no. 2, pp. 289–296, 1995. View at Publisher · View at Google Scholar
  45. A. V. Turnbull and C. L. Rivier, “Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action,” Physiological Reviews, vol. 79, no. 1, pp. 1–71, 1999. View at Google Scholar
  46. G. B. Stefano, V. Prevot, J.-C. Beauvillain, and T. K. Hughes, “Interleukin-10 stimulation of corticotrophin releasing factor median eminence in rats: evidence for dependence upon nitric oxide production,” Neuroscience Letters, vol. 256, no. 3, pp. 167–170, 1998. View at Publisher · View at Google Scholar
  47. A. O'Garra and F. J. Barrat, “In vitro generation of IL-10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by Th1- and Th2-inducing cytokines,” Immunology Letters, vol. 85, no. 2, pp. 135–139, 2003. View at Publisher · View at Google Scholar
  48. C. Hawrylowicz, D. Richards, T.-K. Loke, C. Corrigan, and T. Lee, “A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients,” Journal of Allergy and Clinical Immunology, vol. 109, no. 2, pp. 369–370, 2002. View at Publisher · View at Google Scholar
  49. S. F. Sorrells and R. M. Sapolsky, “An inflammatory review of glucocorticoid actions in the CNS,” Brain, Behavior, and Immunity, vol. 21, no. 3, pp. 259–272, 2007. View at Publisher · View at Google Scholar